Digital wave sweeps SMB sector: AI tools now used by 4 in 5 small businesses, reports Primus Partners
Primus Partners unveiled its latest report, Empowering Small Businesses through Digital Advertising, a comprehensive study based on a survey of…
Stay updated with the latest business news from India. The News Equity covers corporate announcements, market updates, startup stories, CSR initiatives and economic developments across key industries.”
Primus Partners unveiled its latest report, Empowering Small Businesses through Digital Advertising, a comprehensive study based on a survey of…
Vi, India’s leading telecom operator, today announced the launch of industry-first handset theft & loss insurance plans, specifically for prepaid…
The Goods and Services Tax (GST) rationalisation in September 2025, implemented ahead of India’s festive season, appears to have supported…
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE: 532523, NSE: BIOCON), announced today a new settlement and license agreement with Regeneronand Bayer for biosimilar Aflibercept (40mg/ml) in Europe and the rest of the world, which follows an earlier settlement covering the UnitedStates and Canada. This agreement clears the way for Biocon Biologics to commercialize Yesafili®, a biosimilar Aflibercept (40mg/ml), in all countries worldwide. YESAFILI is a vascular endothelial growth factor (VEGF) inhibitor used to treat multiple ophthalmology conditions. Biocon Biologics, Regeneron and Bayer executed the agreement to dismiss all pending litigation. This agreement enables the Company to launch YESAFILI in the United Kingdom in January 2026 and in the rest of the settled countries in March 2026 or earlier in certain circumstances. The other terms of the settlement are confidential.…
Temasek-backed e-commerce enablement platform Shiprocket has filed updated draft papers with markets regulator Sebi to raise a little over Rs…
Vedanta Chairman Anil Agarwal has welcomed the Government of India’s reforms to the oil and gas regulatory framework, calling the…
Meesho Limited (the “Company”) proposes to open the initial public offering (“Offer”) of its equity shares of face value ₹1…
Aequs Limited (The “Company”), shall open the Bid/Offer in relation to its initial public offer of Equity Shares on Wednesday, December…
Vidya Wires Limited (The “Company”), shall open the Bid/Offer in relation to its initial public offer of Equity Shares on December 03,…
Shree Foundation Trust, the social development arm of Shree Cement Ltd., one of India’s leading cement producers, distributed Almadar three-year…